Joel Greenblatt - Gotham Asset Management
Holding/activity history for Gain Therapeutics, Inc. (GANX)
← All GANX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 0.03 | $1.41–2.12 · VW $1.75i | SEC | |
| 2025 Q2 | 245,896 | 0.03 | Add 59.69% | 0.01 | $1.48–2.27 · VW $1.86i | $5,362,992 | SEC |
| 2025 Q1 | 153,984 | 0.03 | Reduce 2.64% | <0.01 | $1.54–2.81 · VW $2.18i | $3,173,610 | SEC |
| 2024 Q4 | 158,155 | 0.04 | Reduce 52.73% | 0.04 | $1.50–3.19 · VW $2.15i | $3,737,203 | SEC |
| 2024 Q3 | 334,592 | 0.08 | Buy | 0.08 | $0.89–2.00 · VW $1.31i | $7,377,754 | SEC |
Price snapshot:
Current price$1.76
52-week low$1.41
52-week high$4.34